I previously rated CCRN a sell, arguing that the FTC could block the merger because of concerns about competition in healthcare markets. The stock price now offers a 45% upside if the Aya merger ...

Find latest technology news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.